- Home
- TRAK vs HURA Comparison
TRAK vs HURA Comparison
Compare TRAK & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRAK | HURA |
|---|---|---|
| Founded | 1990 | 2009 |
| Country | United States | United States |
| Employees | N/A | 22 |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.2M | 160.5M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRAK | HURA |
|---|---|---|
| Price | $7.96 | $2.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 54.5K | ★ 581.0K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 20.69 | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $21,007,076.00 | N/A |
| Revenue This Year | $6.61 | N/A |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | $28.64 | ★ N/A |
| Revenue Growth | ★ 4.84 | N/A |
| 52 Week Low | $6.94 | $0.41 |
| 52 Week High | $18.47 | $3.90 |
Technical Indicators
Market Signals| Indicator | TRAK | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 43.37 |
| Support Level | $8.11 | $2.14 |
| Resistance Level | $9.09 | $2.20 |
| Average True Range (ATR) | 0.28 | 0.14 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 19.39 | 8.51 |
Price Performance
Historical ComparisonAbout TRAK ReposiTrak Inc.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.